Schizophrenia Bulletin

Papers
(The H4-Index of Schizophrenia Bulletin is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Introduction to “The Beginnings of Systematic Studies of the Genetics of Schizophrenia: 1916–1933”80
Correction to: The Difficulties of Grandiose Delusions: Harms, Challenges, and Implications for Treatment Engagement78
66 THE POSITIVE EFFECT OF AEROBIC EXERCISE ON SOCIAL COGNITION IN ADOLESCENTS WITH SCHIZOPHRENIA70
Identify Potential Causal Relationships Between Cortical Thickness, Mismatch Negativity, Neurocognition, and Psychosocial Functioning in Drug-Naïve First-Episode Psychosis Patients63
98 THERAPEUTIC INTERVENTION OF SPORTS PSYCHOLOGICAL EXERCISE THERAPY ON THINKING DISORDERS IN PATIENTS WITH SCHIZOPHRENIA56
50 EFFICACY OF DIARY PSYCHOEDUCATION AND HIERARCHICAL NURSING IN PATIENTS WITH SCHIZOPHRENIA53
Correction to: Traumatic Brain Injury and Risk of Schizophrenia and Other Non-mood Psychotic Disorders: Findings From a Large Inpatient Database in the United States49
Cognitive Control System Gates Insula Processing of Affective Stimuli in Early Psychosis49
Intact Serial Dependence in Schizophrenia: Evidence from an Orientation Adjustment Task47
Service User Representation in Qualitative Research on Cognitive Health and Related Interventions for Psychosis: A Scoping Review43
Psychometric Properties and Diagnostic Associations of the Short-Form Community Assessment of Psychic Experiences in a Population-Based Sample of 29 021 Adult Men43
Focused Ultrasound Stimulates the Prefrontal Cortex and Prevents MK-801-Induced Psychiatric Symptoms of Schizophrenia in Rats42
A Transdiagnostic Study of Effort-Cost Decision-Making in Psychotic and Mood Disorders42
Symptom Structure in Schizophrenia: Implications of Latent Variable Modeling vs Network Analysis41
Comparison of Negative Symptom Network Structures Between Patients With Early and Chronic Schizophrenia: A Network and Exploratory Graph Analysis40
Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial39
Clinical Consequences of Motor Behavior as Transdiagnostic Phenomenon36
Corollary Discharge Dysfunction as a Possible Substrate of Anomalous Self-experiences in Schizophrenia35
Durable Cognitive Gains and Symptom Improvement Are Observed in Individuals With Recent-Onset Schizophrenia 6 Months After a Randomized Trial of Auditory Training Completed Remotely34
Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future Opportunities34
Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials34
Shared Genetic Architecture Among Gastrointestinal Diseases, Schizophrenia, and Brain Subcortical Volumes34
Blinders for Coping With Schizophrenia33
The Role of Fatty Acid Amide Hydrolase, a Key Regulatory Endocannabinoid Enzyme, in Domain-Specific Cognitive Performance in Psychosis33
Of Movies and Madness: Recalling Schizophrenia32
Clinical Recovery Among Individuals With a First-Episode Schizophrenia an Updated Systematic Review and Meta-Analysis30
Effects of Exercise on Structural and Functional Brain Patterns in Schizophrenia—Data From a Multicenter Randomized-Controlled Study30
Environmental Adversity Is Associated With Attenuated Positive Symptoms and Complex Cognition in a Long-term Follow-up of the Philadelphia Neurodevelopmental Cohort30
9 THE CLINICAL INTERVENTION EFFECT OF MINDFULNESS PAINTING ART THERAPY ON ADOLESCENT DEPRESSION PATIENTS30
Longitudinal Associations Between Self-reported Schizotypy Dimensions and White Matter Integrity Development During Adolescence30
Improving our Understanding of Early Psychosis: Learning from the Optimise Trial30
0.030751943588257